|
1
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$52.5M
|
–
|
–
|
–
|
|
|
2
|
|
$27.8M
|
–
|
–
|
–
|
|
|
3
|
BVF Inc
San Francisco,
California
|
$21M
|
–
|
–
|
–
|
|
|
4
|
General Atlantic
New York
|
$14.2M
|
–
|
–
|
–
|
|
|
5
|
Stonepine Capital Management
Bend,
Oregon
|
$13.4M
|
-$1.61M
|
-338,846
|
-11%
|
|
|
6
|
EcoR1 Capital
San Francisco,
California
|
$10M
|
+$1.36M
|
+286,658
|
+16%
|
|
|
7
|
Tang Capital Management
San Diego,
California
|
$8.66M
|
–
|
–
|
–
|
|
|
8
|
|
$5.17M
|
+$1.66M
|
+348,845
|
+48%
|
|
|
9
|
Commodore Capital
New York
|
$4.78M
|
–
|
–
|
–
|
|
|
10
|
Vanguard Group
Malvern,
Pennsylvania
|
$3.7M
|
+$104K
|
+21,897
|
+3%
|
|
|
11
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$3.08M
|
–
|
–
|
–
|
|
|
12
|
Boxer Capital
San Diego,
California
|
$2.74M
|
–
|
–
|
–
|
|
|
13
|
Geode Capital Management
Boston,
Massachusetts
|
$1.52M
|
+$345K
|
+72,483
|
+30%
|
|
|
14
|
State Street
Boston,
Massachusetts
|
$1.27M
|
+$219K
|
+46,073
|
+21%
|
|
|
15
|
Northern Trust
Chicago,
Illinois
|
$697K
|
+$203K
|
+42,724
|
+42%
|
|
|
16
|
|
$640K
|
+$219K
|
+45,927
|
+53%
|
|
|
17
|
Charles Schwab
San Francisco,
California
|
$497K
|
+$78.5K
|
+16,492
|
+19%
|
|
|
18
|
Bridgeway Capital Management
Houston,
Texas
|
$429K
|
+$143K
|
+30,000
|
+51%
|
|
|
19
|
Bank of New York Mellon
New York
|
$257K
|
+$80.5K
|
+16,916
|
+46%
|
|
|
20
|
Nuveen
Charlotte,
North Carolina
|
$129K
|
+$44.5K
|
+9,348
|
+53%
|
|
|
21
|
Bank of America
Charlotte,
North Carolina
|
$97.9K
|
+$58.4K
|
+12,265
|
+152%
|
|
|
22
|
RhumbLine Advisers
Boston,
Massachusetts
|
$80.7K
|
+$23.3K
|
+4,885
|
+41%
|
|
|
23
|
|
$79.2K
|
+$78.4K
|
+16,460
|
New
|
|
|
24
|
Prelude Capital Management
New York
|
$76.2K
|
+$75.4K
|
+15,842
|
New
|
|
|
25
|
|
$74.7K
|
+$1.23K
|
+258
|
+2%
|
|
